Summary Retinoids can reverse potentially premalignant lesions and prevent second primary tumours in patients with head and neck squamous cell carcinoma (HNSCC). Furthermore, it has been reported that acquired resistance to all-trans retinoic acid (RA) in leukaemia is associated with decreased plasma peak levels, probably the result of enhanced retinoid metabolism. The aim of this study was to investigate the metabolism of retinoids and relate this to growth inhibition in HNSCC. Three HNSCC cell lines were selected on the basis of a large variation in the all-trans RA-induced growth inhibition. Cells were exposed to 9.5 nm (radioactive) for 4 and 24 h, and to 1 and 10 gM (nonradioactive) all-trans RA for 4, 24, 48 and 72 h, and medium and cells were analysed for retinoid metabolites. At all concentrations studied, the amount of growth inhibition was proportional to the extent at which all-trans-, 13-and 9-cis RA disappeared from the medium as well as from the cells. This turnover process coincided with the formation of a group of as yet unidentified polar retinoid metabolites. The level of mRNA of cellular RA-binding protein 11 (CRABP-11), involved in retinoid homeostasis, was inversely proportional to growth inhibition. These findings indicate that for HNSCC retinoid metabolism may be associated with growth inhibition.
head and neck (Linnman et al, 1988) . Thus far, retinoids appear to be active in early-stage HNSCC, but their utility is limited by the interpatient variability with respect to not only response, but also to side-effects. Another characteristic of treatment of HNSCC with retinoids is that discontinuation of treatment leads invariably to recurrence of the lesion (Hong and Itri, 1994) .
It is not known how retinoids are actually able to regulate growth control. The association between vitamin A deficiency and the development of cancer suggests that the intracellular retinoid-dependent pathways play a role in cancer development. Most of the actions of retinoids are thought to result from changes in gene expression mediated by nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs) (Mangelsdorf et al, 1994) . Retinoids bind to these receptors, which act as transcription factors upon dimerization. The expression of one such RAR-3, as determined by in situ hybridization was found to be selectively absent in 31 of 52 leucoplakia cases and could be restored by treatment with 13-cis RA (Lotan et al, 1995) . Restoration of expression is associated with a clinical response to 13-cis RA. However, pretreatment levels of RAR-P do not predict the clinical response (Lotan et al, 1995) . Sixty-five per cent of clinical HNSCC samples show a lack of RAR-, expression, as judged by in situ hybridization . No association, however, was found in HNSCC cell lines between all-trans RA sensitivity and the expression of RARs, RXRs and the cellular retinoic acid-binding proteins (CRABP) (Zou et al, 1994) .
All-trans RA induces complete remission in most patients with acute promyelocytic leukaemia. However, relapses are frequent and resistance to the drug is developing. This resistance is associated with unexpectedly low plasma levels of retinoids despite continued treatment (Muindi et al, 1994) . The interindividual variation in retinoid pharmacokinetics is already known from other studies (Eckhoff et al, 1991; Adamson et al, 1993; Lee et al, 1993) , and it is hypothesized that the variability in the pharmacokinetics of all-trans RA may result from differences in catabolic rates determined or influenced by genetic or environmental factors. Thus, a poor metabolism may be associated with a response, whereas enhanced retinoid metabolism is associated with acquired therapy resistance (Muindi et al, 1994) . CRABP-II levels may be the cause of this resistance, as increased levels of this enzyme have been found in tumour cells from relapsed patients treated with alltrans RA (Delva et al, 1993) . Also, the oxidative breakdown via the cytochrome P450 enzyme system is a possible explanation (Rigas et al, 1993) . Two lines of evidence for the latter possibility have been provided: a tenfold increase in the 4-oxo-all-trans RA glucuronide has been found in the urine of relapsed patients (Muindi et al, 1994) and ketoconazole and liarozole, inhibitors of the cytochrome P450 system, are able to attenuate this catabolism (Wouters et al, 1992; Rigas et al, 1993) .
In vitro, variation in growth inhibition after exposure of HNSCC to all-trans RA has been reported (Jetten et al, 1990; Sacks et al, 1995) , and thus far this variation cannot be explained (Zou et al, 1994) . The aim of this study was to investigate the presence or absence of a variation in retinoid metabolism between HNSCC cell lines and whether this is related to the degree of growth inhibition by all-trans RA.
MATERIALS AND METHODS
Cell lines HNSCC cell lines were obtained from Dr TE Carey, University of Michigan, Ann Arbor, MI, USA, and are described elsewhere (Carey, 1985) . UM-SCC-14C originated from a local recurrence of cancer of the floor of the mouth, UM-SCC-22A and -35 from hypopharyngeal tumours. Cells were cultured routinely in DMEM (Dulbecco's modified Eagle medium, ICN Biomedicals, Irvine, UK) with 5% fetal calf serum (FCS, Flow Laboratories) in 75-cm2 flasks (Nunc, Roskilde, Denmark) . Cellular doubling times were 26 h for UM-SCC-14C, 52 h for UM-SCC-35 and 34 h for the UM-SCC-22A cell line.
Chemicals
All-trans RA was obtained from Acros Chimica (Geel, Belgium), 4-oxo-trans-and cis-RA were kind gifts of Hoffmann-la Roche, Basle, Switzerland; retinol and 13-cis-RA were obtained from Sigma (St Louis, MO, USA). All compounds were dissolved as a 10-2 M stock in dimethylsulphoxide (DMSO, JT Baker, Deventer, The Netherlands) and stored at -80°C. For each experiment freshly prepared solutions were made, the first (10-3 M) being made with DMSO. Subsequent dilutions were prepared in cell culture medium. All handling with retinoids was performed in subdued light, tubes were wrapped in aluminium foil and oxidation was prevented by replacing the air by nitrogen.
Cell growth inhibition studies
Effects on the growth of HNSCC cells were determined using the 'SRB assay'. Details of the assay, which measures the cellular protein content, reflecting the actual cell number, have been described previously (Braakhuis et al, 1993 (pH 7.4, PBS) , scraped in 1 ml of PBS and collected by centrifugation. Cell pellets were stored at -80°C until extraction. Retinoids were extracted and analysed by reversed-phase highperformance liquid chromatography (HPLC) as described previously (Pijnappel et al, 1993) . The following standards were included: 13-and 9-cis-and all-trans RA. The experiment was performed in duplicate.
Exposure to non-radioactive all-trans RA Cells were cultured to near confluence in 75-cm2 flasks with 5 ml of medium (DMEM plus FCS). The cells were exposed to 10 and 1 gM all-trans RA. At each time point (0, 4, 24, 48 and 72 h) 500 tl of the supematant was taken from a separate flask and stored at -80°C in the dark until analysis. For the analysis of the intracellular concentration of retinoids, the flasks were washed twice with fresh PBS (pH 7.4) and the cells were trypsinized. The number of living cells (determined with trypan blue) was calculated and cell pellets were washed twice with PBS and stored at -80°C in the dark.
Non-radioactive retinoids were determined by reversed-phase HPLC after extraction with acetonitrile (Teerlink et al, 1997) . A Waters (Milford, MA, USA) HPLC system was used, consisting of a model 717 plus automatic sample injector, a model 616 gradient pump, a model 486 UV detector, and a temperature control module and column heater. Mobile phase was degassed online using a model DG2410 degasser from Uniflows (Tokyo, Japan). Millennium 2010 software from Waters was used for instrument control and data acquisition. Separation was performed on a Spherisorb ODS2 3-im column (100 x 4.6 mm) from Phase Separations (Deeside, UK) maintained at 30°C. Composition of the mobile phases and the binary gradient used were as described by Eckhoff and Nau (1990) . UV detection was performed at 340 nm and retinoids were identified using external standardization. We included the following standards: 4-oxo-trans RA, 4-oxocis RA, 13-cis RA, all-trans RA and retinol. As we also intended to measure the levels of unknown retinoid metabolites, the results were expressed as a percentage of the total area under the curve of the relevant part of the chromatogram (retention time between 6 and 30 min).
Measurement of CRABP mRNA levels Total RNA was isolated from cultured cells according to Gough (1988) . Total RNA (20 jg) was loaded on a 1% agarose formaldehyde gel and electrophoresed in 3-(N-morpholine)-propane sulphonic acid (MOPS) buffer essentially as described by Sambrook et al (1989) . The RNA was Northern blotted by capillary transfer in 10 x saline sodium citrate (SSC) (Sambrook et al, 1989) onto genescreen plus filters (Dupont NEN). The filter was baked for 2 h at 80°C, prehybridized in 7% sodium dodecyl sulphate (SDS), 0.5 M sodium phosphate buffer, 2 mm EDTA, pH 7.0, for 2 h at 65°C, and after addition of the denatured probe, hybridized at 65°C for 16 h. The probes were made by labelling the isolated 0.6-kb XbaV/BamHI fragment containing human CRABP-I cDNA (Astrom et al, 1991) , the 1-kb EcoRI fragment containing human CRABP-II cDNA (Astrom et al, 1991) and the 0.2-kb fragment containing part of 18S rRNA cDNA with [a-32P]dCTP to a specific activity of approximately 109 dpm jigby multiprimed elongation (Feinberg and Vogelstein, 1983) . After hybridization the filters were washed twice with 2 x SSC, 0.2% SDS and twice with 0.2 x SSC, 0.2% SDS, at 65°C for 15 min, and the bands visualized by autoradiography with Kodak X-AR 5 film using intensifying screens. 18S rRNA was used as an internal standard to correct for the amount of RNA loaded on the gel.
RESULTS

Inhibition of cell proliferation
The three HNSCC cell lines were selected for their considerable difference in their response to all-trans RA ( Figure IA) . was the most sensitive line with an IC50 value of 6.8 nm. UM-SCC-14C showed hardly any response, even after exposure to the relatively high concentration of 10-5 M. The third line, UM-SCC-22A, showed an intermediate type of response, with a moderate growth inhibition at the broad concentration range from 10-5 to 10-9 M.
Metabolism of 9.5 nM[3H]all-trans RA
The fate of [3H]all-trans RA was studied in the media and the cell pellets of all three cell lines. The cells were exposed to 9.5 nm alltrans RA, a concentration that is in the range found in human plasma (Eckhoff et al, 1991) . The concentration of [3H]all-trans RA decreased in the medium and the time dependency of this effect differed between the cell lines ( Figure 2) . In UM-SCC-35 this decrease started at 4 h and led to a total loss at 24 h exposure ( Figure 2G and H). A similar decrease was seen for 9-and 13-cis RA. For this cell line the contribution of all-trans RA to the total amount of retinoids was relatively low, being 22% at 4 h and 1.4% at 24 h. For the insensitive line, UM-SCC-14C, the concentration of all-trans RA in the medium was the highest (19.5%) of all three cell lines at 24 h ( Figure 2C and D) and for the UM-SCC-22A a somewhat lower value (9.4%) was observed ( Figure 2E and F).
The HPLC method of analysis enabled us to measure retinoid metabolites. In the media of the cell cultures a number of peaks could be detected after 4 and 24 h exposure to [3H]all-trans RA, corresponding to retention times between 2 and 20 min (Figure 2 ).
For UM-SCC-35 these peaks formed at 24 h the majority (86 %) of the total of labelled retinoids. These polar metabolites were less prevalent in the two other cell lines, being 49% and 68% for UM-SCC-14 and 22A respectively. As the intracellular recovery was rather low, varying between 0.2% and 2.5% of the total amount of radioactivity added, only estimations of retinoid levels could be made. Intracellular retinoid levels decreased in the course of time. UM-SCC-35 had the lowest British Journal of Cancer (1997) 76(2), [189] [190] [191] [192] [193] [194] [195] [196] [197] 0 Cancer Research Campaign 1997 When exposed to 1 gM all-trans RA, retinoid metabolites were measured after various time points (Figure 3 and Table 1 ). In general, the pattern is similar to that seen with the exposure to the lower concentration, but the effect was less dramatic. Because now the exposure time is longer, the kinetics of disappearance of British Journal of Cancer (1997) 76(2), [189] [190] [191] [192] [193] [194] [195] [196] [197] the retinoids can be studied in more detail. The the major retinoids from the medium was high SCC-35 cell line. After 24 h this is already ver reaches an apparent plateau at 48 h with 10% of t The disappearance of retinoids from the other more gradual, UM-SCC-14C being the slowest regard to the composition of the retinoids a observed: the contribution of the unidentifiable p visible as a number of peaks with retention times 1 min, actually increased. These metabolites coulc all three cell lines, but was most remarkable f followed in order by UM-SCC-22A and -14C. high-performance liquid chromatogram of UM-S exposure is given in Figure 4 .
After exposure to I ltM all-trans RA, UM-. lowest and UM-SCC-22A the highest levels retinoids. The intracellular concentrations were considered accurate. Generally speaking, retinoid in the course of time, but no polar metabolites cot When the cells of the three cell lines were expo trans RA, the pattern seen was similar to that wit sure experiments (data not shown).
Growth inhibition by retinoid metabolites
We wished to investigate whether growth inhibition in the UM-SCC-35 cell line could be caused by the excessive formation of one 4 or more toxic retinoid metabolites. To test this hypothesis we performed two types of experiments. Two cell lines were exposed to a well-known polar metabolite of all-trans RA, 4-oxo-trans RA. This compound was found to induce growth inhibition in the UM- cultures. It appears that newly formed retinoids are less potent with shift could be respect to growth inhibition than the parent compounds they were olar metabolites, derived from, but it must be added that, on an individual basis, the between 6 and 21 concentration of these metabolites is significantly lower than the I be detected for concentration of parent retinoid (Table 1) .
Anr exaMpleCof Measurement of CRABP expression
,An example of CC-35 after 24 h CRABP-I and -II are proteins involved in retinoid homeostasis and they may be important with respect to metabolism and growth SCC-35 had the inhibition. We therefore analysed CRABP-I and -II expression by of intracellular Northern blotting and hybridization. CRABP-I had undetectable too low to be transcript levels in all cell lines, confirming previous results (Zou levels decreased et al, 1994) . The analysis of CRABP-II showed that UM-SCC-35 uld be detected.
had considerably lower transcript levels than the other two cell )sed to 10 JM alllines ( Figure 5 ). Exposure to 10-6 M all-trans RA for 24 h had an th the 1 ,UM expoapparent down-regulating effect on CRABP-II mRNA levels in UM-SCC-14C and -22A.
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DISCUSSION
In this study of three HNSCC cell lines, it was shown that the extent of all-trans RA-induced growth inhibition is proportional to a decrease in retinoid levels in cells and the corresponding culture medium. In the culture medium without cells, which was taken as a control, the extent of retinoid disappearance was minimal, leading to the interpretation that the removal of retinoids from the medium is a cell-mediated process. This disappearance of retinoids coincided with the production of retinoid metabolites, detectable in the medium. Thus, the major finding of this study is that the extent of metabolism is proportional to the degree of growth suppression. This suggests that retinoid metabolism is associated with growth inhibition. Interestingly, this relation has also been found for breast carcinoma cell lines (Takatsuka et al, 1996 ; BM van der Leede et al, manuscript in preparation). It has been reported that, in a proportion of patients treated continuously for leukaemia with all-trans RA, some have lower blood plasma retinoid levels at 28 days than during the first cycles of treatment (Muindi et al, 1992) . This lowering of retinoid plasma levels is proposed to be the result of an induced metabolism that eventually leads to the development of therapy resistance (Martini and Murray, 1993) . Thus, hypothetically, two phenotypes of 'rapid' and 'slow catabolizers' can be discriminated in the population of leukaemia patients (Rigas et al, 1993) . Our present data, however, indicate that the ability of HNSCC cells to metabolize is related not to resistance, but rather to a growth-inhibitory effect. This paradox may be explained by the fact that various cell types could differ in retinoid requirement, turnover and induction of growth inhibition, as has been shown for the first two aspects to be the case for a variety of tissue types (Kurlandsky et al, 1995) .
Membrane transport is most likely not an important variable in explaining a difference in growth inhibition. Retinol and retinoic acid are preferably bound to proteins and passive diffusion most likely determines cellular uptake (Blaner and Olson, 1994) . Differences in uptake between the cell lines that have been studied in the present report, however, cannot be excluded, and a 63-kDa receptor, recently described to be involved in retinol uptake (Bavik et al, 1993) , may be involved in this process.
An important question that remains to be answered is whether metabolism is the cause or the consequence of growth modulation. First, the hypothesis can be formulated that intracellular turnover of retinoids is the driving force causing growth inhibition. In case of sensitivity, as soon as retinoic acid enters the cell in either the cis or the trans form, it is very efficiently metabolized to one or more cytotoxic polar compounds. In the most sensitive line studied here, turnover is very efficient; at the physiological concentration of 9.5 nm the majority of the original concentration of all detectable retinoids has disappeared from the medium after 24 h. The remainder of the labelled compound may have become too polar to be detected with the currently used eluent. In the culture medium of this sensitive cell line the majority of the detectable Figure 4 ). T= 0 has been set at 100%. bA peak was observed between all-trans RA and 13-cis RA and based on literature data this peak was identified to represent 9-cis RA. cThis refers to compounds identified by peaks with a retention time between 6 and 21 min (see Figure 4) . aThis refers to compounds identified by peaks with a retention time between 21 and 30 min, with the exception of the known retinoids, under detection limit. retinoids are present in the form of 'polar metabolites'. It is conceivable that a sensitive cell line has a relatively high expression of the enzymes involved in metabolism, for example oxidative enzymes such as the cytochrome P450s (Martini and Murray, 1993; Rigas et al, 1993) . The question arises whether unidentified metabolites also have growth-inhibitory activity. Although it has been reported that the 4-oxo-retinoic acid derivatives are considered breakdown products in humans (Eckhoff et al, 1991) , these molecules have also a transcription-activating capacity (Pijnappel et al, 1993) . In addition, 4-oxo derivation of retinal to 4-oxoretinaldehyde and the subsequent conversion to 4-oxoretinoic acid and 4-oxoretinol is suggested to be an important step during Xenopus embryogenesis (Blumberg et al, 1996) . That study also showed that all these 4-oxo products were able to bind to and transactivate RARs. Our results also show that oxo derivatives have growth-inhibiting capacity ( Figure IB) . The experiments with conditioned medium provided no evidence that the sensitive UM-SCC-35 cells produced a 'suicide' retinoid. The lack of effect of the conditioned medium to produce growth inhibition, however, could be attributed to the fact that the levels of the specific metabolite were too low, perhaps because of further degradation. The peaks corresponding to the levels of the known 4-oxo-oxidation products were rather low. A second hypothesis can be formulated on the relationship between growth inhibition and metabolism. Retinoid metabolism is a secondary event and is an attempt by the cell to neutralize the growth-inhibiting effect. In this scenario, all-trans RA and/or 1 3-cis RA are the key retinoids that cause growth inhibition and the other metabolites must be considered as breakdown products. This hypothesis is further supported by the notion that conditioned medium of the insensitive cell line containing high levels of alltrans-and 13-cis RA appeared to be still very growth inhibitory for the UM-SCC-35 cells. In addition, the expression of CRABP-II mRNA is in further favour of this hypothesis. It has been suggested that CRABP forms an intracellular buffer if the RA concentration exceeds a certain level (Astrom et al, 1991; Adamson et al, 1993; Bavik et al, 1993; Delva et al, 1993; Griffiths et al, 1993; Blaner and Olson, 1994; Napoli et al, 1995) . The present study supports this theory, as the most sensitive cell line was found to have the lowest levels of CRABP-II, and the addition of more RA failed to increase its synthesis. In contrast, Zou et al (1994) reported that CRABP-II expression was not related to retinoid sensitivity in four HNSCC cell lines. An argument against the relation between high CRABP-II levels and insensitivity is the fact that all-tranis treatment does not up-but rather down-regulates CRABP-II mRNA expression. This phenomenon has already been observed for other epithelial cell lines (Sanquer et al, 1993; Zou et al, 1994) . The data, taken together, suggest that CRABP expression can be important but that no general rule can be formulated. Further studies should elucidate the importance of these molecules, and the possibility that the amount of protein is more important than the level of transcription cannot be excluded. The positive correlation between a CRABP expression and metabolism as has been found for CRABP-I in F9 teratocarcinoma stem cells (Boylan and Gudas, 1992 ) is in contrast with the currently reported results. The differences in the types of cells and the function of these proteins may explain this discrepancy.
The levels of retinol in the medium of UM-SCC-35 cells remain high during the course of the exposure and deserve special attention.
The relatively low consumption of retinol from the medium of UM-SCC-35 suggests that the cells are not able to use retinol as a retinoid source to produce retinoic acid. A low activity of one or more enzymes of the group of alcohol dehydrogenases, involved in the conversion of retinol to retinoic acid, may be responsible for such an effect (Harding and Duester, 1992; Napoli et al, 1995) . As a consequence the cells may have adapted themselves to low intracellular levels of all-tranis RA. Theoretically, any excess of all-trans RA is not adequately buffered and may lead to cell death. This concept is in agreement with the hypothesis that metabolism is a secondary event.
One can only speculate about the mechanism responsible for retinoid induced growth inhibition. Studies on leucoplakia by Lotan et al (1995) suggest that the induction of expression of RAR-3 is important for growth suppression. The same group, however, could not find such a correlation when studying malignant HNSCC cell lines . We have also found no indication that the expression per se or induction by retinoic acid of RAR-o and -y, and RXR-ix is related to sensitivity of the cell lines used (Copper et al, 1997) . RAR-f mRNA levels were too low to be measured. A recent in vitro study on breast cancer cells showed that RAR-a antagonists were as efficient in inhibiting growth as agonists (Dawson et al, 1995) . This indicates that binding of a retinoid to a RAR may be important but that transcriptional activation on a retinoic acid-responsive element (RARE) is not a prerequisite. It is not clear whether this finding can be extrapolated to the in vivo situation and whether it can be extended to other tumour types. No indications are available that RAR-u. is important in growth inhibition of HNSCC.
